Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Hyaluronidase · Amphadase, Hylenex Recombinant

Recombinant protein · Acts on Hyaluronic acid · developed by Bausch And Lomb

Approved FDA, May 2004
1 Registered trials

What is Hyaluronidase?

Hyaluronidase is an endoglycosidase that hydrolyzes hyaluronic acid in connective tissue, temporarily reducing its viscosity and increasing tissue permeability. It is used as an adjuvant to aid subcutaneous fluid administration, the dispersion and absorption of other injected drugs, and subcutaneous urography. Amphadase was also studied in intradermal injections in subjects with an allergic skin reaction.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Amphadase, Hylenex Recombinant, Vitrase
Drug type
Recombinant protein
Targets
Hyaluronic acid
Mechanism
Acts on Hyaluronic acid
Pathways
hyaluronic acid hydrolysis, connective tissue permeability
Therapy area
Immunology
Developer
Bausch And Lomb
In trials of
AMPH, REGN
FDA status
Approved as Amphadase, Hylenex Recombinant, Vitrase (May 5, 2004), BLA021640 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Nov 11, 2024). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT01689363 Phase 2 Allergic Skin Reaction Completed AMPH

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Allergic Skin Reaction

Sources

Updated Nov 8, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.